Skip to main content
. 2021 Oct 23;12(11):993. doi: 10.1038/s41419-021-04297-0

Fig. 1. High LSD1 expression predicts a poor prognosis in HNSCC patients.

Fig. 1

A The expression levels of LSD1 were detected in different types of cancers from the GEPIA public database. B The GEPIA database revealed that LSD1 expression was significantly upregulated in HNSCC patients. C Correlation between the expression level of LSD1 and the pathological stage of HNSCC patients (GEPIA). D Representative images of LSD1 expression in normal tissues, leukoplakia tissues, and HNSCC tissues via immunohistochemical (IHC) staining. Scale bar: 100 μm. E IHC scores for LSD1 expression in normal, leukoplakia, and HNSCC tissues. F IHC scores for LSD1 expression in HNSCC samples in different TNM stages. G IHC scores for LSD1 expression in HNSCC with different grades. H High LSD1 expression significantly correlates with poor survival in HNSCC patients. The survival rates of patients with LSD1-low and LSD1-high tumors (P < 0.01) were determined using Kaplan–Meier survival test. (*p < 0.05, **p < 0.01).